Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Impact homolog pseudogene" (ENSG00000256465) is a human pseudogene, derived by duplication or retrotransposition from a functional IMPACT gene ancestor.[1][2][7] Pseudogenes are generally defined as DNA sequences with close homology to functional genes but that have lost their ability to code for functional proteins, either because of disruptive mutations (such as premature stop codons or indels) or loss of regulatory regions.[1][4] Although some pseudogenes can be transcribed or may play minor roles as regulators of gene expression (e.g., via RNA interference or as competing endogenous RNA sponges), in the vast majority of cases—including this one—no protein product is made and there is no evidence of physiological, pathological, or pharmacological relevance.[2][7] This pseudogene is not a canonical drug target and has no known role as a biomarker or in disease, nor does it interact with therapeutic agents.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Impact homolog pseudogene.